MedPath

A Study of Pain Relief in Osteoarthritis

Phase 3
Completed
Conditions
Osteoarthritis
Interventions
Registration Number
NCT00298974
Lead Sponsor
Abbott
Brief Summary

The purpose of this study is to compare the safety and pain-relieving ability of Vicodin CR to placebo in subjects with osteoarthritis (OA) of the hip or knee.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
873
Inclusion Criteria
  • Males and females ages 21 to 80
  • If female, must be of non-child bearing potential or practicing birth control
  • Has osteoarthritis of the hip or knee
  • Requires therapeutic doses of medication for osteoarthritis pain
  • Has sufficient pain to justify the use of around-the-clock opioids
Exclusion Criteria
  • Is associated with any currently ongoing research study, or has previously participated in a Vicodin CR study
  • Is allergic to or has had a serious reaction to hydrocodone, other opioids, or acetaminophen
  • Cannot discontinue pain medications, even for the short time prior to the study start
  • Has any clinically significant illness or recent injury, or has any significant laboratory abnormality, or has recently had major surgery
  • Has a history of gastric bypass surgery or preexisting severe gastrointestinal narrowing, or history of diseases that may narrow the gastrointestinal tract
  • Has a history of malnutrition or starvation
  • Has a history of drug (licit or illicit) or alcohol abuse or addiction, or consumes more than 4 alcoholic drinks per day
  • Has a history of a major depressive episode within the past 2 years, or requires treatment with certain drugs for depression, or has a history of major psychiatric disorder
  • Pregnant or breastfeeding females
  • Is incapacitated, bedridden or confined to a wheelchair
  • Has initiated any new therapy or medication for OA within 1 month of screening
  • Has had surgery, certain types of procedures, or received certain medications for osteoarthritis within a specified time frame
  • Has other conditions that may cause pain, such as rheumatoid arthritis or gout

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PlaceboPlacebo-
hydrocodone/acetaminophen extended releasehydrocodone / acetaminophen extended release-
Primary Outcome Measures
NameTimeMethod
Pain Intensity12 weeks

Arthritis Pain Intensity measured by a 100mm Visual Analog Scale (VAS)

Secondary Outcome Measures
NameTimeMethod
Pain intensity difference (PID) from baseline to each scheduled evaluation12 weeks
Western Ontario and McMaster (WOMAC) Osteoarthritis Index total score12 weeks
SF-36v2 Health Status Survey12 weeks

Trial Locations

Locations (83)

Site Ref # / Investigator 393

🇺🇸

Tucson, Arizona, United States

Site Ref # / Investigator 526

🇺🇸

Anaheim, California, United States

Site Ref # / Investigator 721

🇺🇸

Los Angeles, California, United States

Site Ref # / Investigator 715

🇺🇸

Fall River, Massachusetts, United States

Site Ref # / Investigator 457

🇺🇸

Pembroke Pines, Florida, United States

Site Ref # / Investigator 437

🇺🇸

Marietta, Georgia, United States

Site Ref # / Investigator 2419

🇺🇸

St. Louis, Missouri, United States

Site Ref # / Investigator 582

🇺🇸

Columbus, Ohio, United States

Site Ref # / Investigator 558

🇺🇸

Dallas, Texas, United States

Site Ref # / Investigator 388

🇺🇸

Longwood, Florida, United States

Site Ref # / Investigator 357

🇺🇸

Fair Oaks, California, United States

Site Ref # / Investigator 709

🇺🇸

Littleton, Colorado, United States

Site Ref # / Investigator 453

🇺🇸

Tempe, Arizona, United States

Site Ref # / Investigator 420

🇺🇸

Ocala, Florida, United States

Site Ref # / Investigator 584

🇺🇸

Tucson, Arizona, United States

Site Ref # / Investigator 580

🇺🇸

Mobile, Alabama, United States

Site Ref # / Investigator 497

🇺🇸

Clearwater, Florida, United States

Site Ref # / Investigator 2421

🇺🇸

Sierra Vista, Arizona, United States

Site Ref # / Investigator 417

🇺🇸

Daytona Beach, Florida, United States

Site Ref # / Investigator 481

🇺🇸

St. Petersburg, Florida, United States

Site Ref # / Investigator 583

🇺🇸

Wheat Ridge, Colorado, United States

Site Ref # / Investigator 434

🇺🇸

Plantation, Florida, United States

Site Ref # / Investigator 474

🇺🇸

Miami, Florida, United States

Site Ref # / Investigator 416

🇺🇸

Cleveland, Ohio, United States

Site Ref # / Investigator 423

🇺🇸

Birmingham, Alabama, United States

Site Ref # / Investigator 543

🇺🇸

Phoenix, Arizona, United States

Site Ref # / Investigator 2582

🇺🇸

Phoenix, Arizona, United States

Site Ref # / Investigator 508

🇺🇸

Oklahoma City, Oklahoma, United States

Site Ref # / Investigator 581

🇺🇸

Birmingham, Alabama, United States

Site Ref # / Investigator 459

🇺🇸

Birmingham, Alabama, United States

Site Ref # / Investigator 479

🇺🇸

Phoenix, Arizona, United States

Site Ref # / Investigator 439

🇺🇸

San Diego, California, United States

Site Ref # / Investigator 521

🇺🇸

Cincinnati, Ohio, United States

Site Ref # / Investigator 724

🇺🇸

Cincinnati, Ohio, United States

Site Ref # / Investigator 476

🇺🇸

San Antonio, Texas, United States

Site Ref # / Investigator 727

🇺🇸

San Antonio, Texas, United States

Site Ref # / Investigator 2420

🇺🇸

San Antonio, Texas, United States

Site Ref # / Investigator 450

🇺🇸

Salt Lake City, Utah, United States

Site Ref # / Investigator 411

🇺🇸

Omaha, Nebraska, United States

Site Ref # / Investigator 2430

🇺🇸

Portland, Oregon, United States

Site Ref # / Investigator 489

🇺🇸

Plantation, Florida, United States

Site Ref # / Investigator 433

🇺🇸

Ocala, Florida, United States

Site Ref # / Investigator 533

🇺🇸

Buena Park, California, United States

Site Ref # / Investigator 366

🇺🇸

Jupiter, Florida, United States

Site Ref # / Investigator 505

🇺🇸

DeLand, Florida, United States

Site Ref # / Investigator 359

🇺🇸

Oldsmar, Florida, United States

Site Ref # / Investigator 719

🇺🇸

Port Orange, Florida, United States

Site Ref # / Investigator 2598

🇺🇸

Meridian, Idaho, United States

Site Ref # / Investigator 458

🇺🇸

West Palm Beach, Florida, United States

Site Ref # / Investigator 2594

🇺🇸

Tampa, Florida, United States

Site Ref # / Investigator 550

🇺🇸

Chicago, Illinois, United States

Site Ref # / Investigator 418

🇺🇸

Pasadena, Maryland, United States

Site Ref # / Investigator 355

🇺🇸

Louisville, Kentucky, United States

Site Ref # / Investigator 523

🇺🇸

Newburgh, Indiana, United States

Site Ref # / Investigator 468

🇺🇸

Owings Mills, Maryland, United States

Site Ref # / Investigator 527

🇺🇸

West Yarmouth, Massachusetts, United States

Site Ref # / Investigator 560

🇺🇸

Brockton, Massachusetts, United States

Site Ref # / Investigator 529

🇺🇸

Biloxi, Mississippi, United States

Site Ref # / Investigator 522

🇺🇸

Wellesley Hills, Massachusetts, United States

Site Ref # / Investigator 2544

🇺🇸

Florissant, Missouri, United States

Site Ref # / Investigator 389

🇺🇸

Mamaroneck, New York, United States

Site Ref # / Investigator 501

🇺🇸

Roslyn, New York, United States

Site Ref # / Investigator 528

🇺🇸

New York, New York, United States

Site Ref # / Investigator 525

🇺🇸

Centerville, Ohio, United States

Site Ref # / Investigator 349

🇺🇸

Winston-Salem, North Carolina, United States

Site Ref # / Investigator 452

🇺🇸

Monroe, North Carolina, United States

Site Ref # / Investigator 723

🇺🇸

Eugene, Oregon, United States

Site Ref # / Investigator 530

🇺🇸

Zanesville, Ohio, United States

Site Ref # / Investigator 713

🇺🇸

Mechanicsburg, Pennsylvania, United States

Site Ref # / Investigator 504

🇺🇸

Milan, Tennessee, United States

Site Ref # / Investigator 486

🇺🇸

West Reading, Pennsylvania, United States

Site Ref # / Investigator 466

🇺🇸

Greenville, South Carolina, United States

Site Ref # / Investigator 493

🇺🇸

Duncansville, Pennsylvania, United States

Site Ref # / Investigator 351

🇺🇸

Cranston, Rhode Island, United States

Site Ref # / Investigator 425

🇺🇸

Greer, South Carolina, United States

Site Ref # / Investigator 350

🇺🇸

Austin, Texas, United States

Site Ref # / Investigator 454

🇺🇸

Chesapeake, Virginia, United States

Site Ref # / Investigator 435

🇺🇸

Virginia Beach, Virginia, United States

Site Ref # / Investigator 556

🇺🇸

Virginia Beach, Virginia, United States

Site Ref # / Investigator 503

🇺🇸

Virginia Beach, Virginia, United States

Site Ref # / Investigator 2599

🇺🇸

Spokane, Washington, United States

Site Ref # / Investigator 410

🇺🇸

New Orleans, Louisiana, United States

Site Ref # / Investigator 511

🇺🇸

Evansville, Indiana, United States

© Copyright 2025. All Rights Reserved by MedPath